无植入式心脏复律除颤器的心律失常性右心室心肌病的危险分层
Risk Stratification in Arrhythmic Right Ventricular Cardiomyopathy Without Implantable Cardioverter-Defibrillators.
作者信息
Brun Francesca, Groeneweg Judith A, Gear Kathleen, Sinagra Gianfranco, van der Heijden Jeroen, Mestroni Luisa, Hauer Richard N, Borgstrom Mark, Marcus Frank I, Hughes Trina
机构信息
Cardiovascular Department, Ospedali Riuniti and University of Trieste, Trieste, Italy.
Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands; Interuniversity Cardiology Institute of the Netherlands (ICIN-Netherlands Heart Institute), Utrecht, The Netherlands.
出版信息
JACC Clin Electrophysiol. 2016 Oct;2(5):558-564. doi: 10.1016/j.jacep.2016.03.015. Epub 2016 Jun 1.
Abstract
OBJECTIVES
The primary objective of this study is risk stratification of patients with arrhythmic right ventricular cardiomyopathy (ARVC).
BACKGROUND
There is a need to identify those who need an automatic implantable defibrillator (ICD) to prevent sudden death.
METHODS
This is an analysis of 88 patients with ARVC from three centers who were not treated with an ICD.
RESULTS
Risk factors for subsequent arrhythmic deaths were pre-enrollment sustained or nonsustained ventricular tachycardia (VT) and decreased left ventricular function.
CONCLUSION
These factors serve as proposed guidelines for implantation of an ICD in patients with ARVC to prevent sudden death.
摘要
目的
本研究的主要目的是对心律失常性右室心肌病（ARVC）患者进行危险分层。
背景
有必要识别出那些需要植入自动植入式除颤器（ICD）以预防猝死的患者。
方法
这是一项对来自三个中心的88例未接受ICD治疗的ARVC患者的分析。
结果
后续心律失常性死亡的危险因素为入组前持续性或非持续性室性心动过速（VT）以及左心室功能下降。
结论
这些因素可作为ARVC患者植入ICD以预防猝死的拟议指南。
相似文献
1
Risk Stratification in Arrhythmic Right Ventricular Cardiomyopathy Without Implantable Cardioverter-Defibrillators.无植入式心脏复律除颤器的心律失常性右心室心肌病的危险分层
JACC Clin Electrophysiol. 2016 Oct;2(5):558-564. doi: 10.1016/j.jacep.2016.03.015. Epub 2016 Jun 1.
2
Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.表型表达是致心律失常性右室心肌病发生恶性心律失常事件和心源性猝死的前提条件。
Europace. 2016 Jul;18(7):1086-94. doi: 10.1093/europace/euv205. Epub 2015 Jul 2.
3
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator.心律失常性右室心肌病的心律失常风险预测：心律失常性右室心肌病风险计算器的外部验证。
Eur Heart J. 2022 Aug 21;43(32):3041-3052. doi: 10.1093/eurheartj/ehac289.
4
Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Without an Implantable Cardioverter-Defibrillator.致心律失常性右室心肌病/发育不良患者的风险分层，无需植入式心脏复律除颤器。
JACC Clin Electrophysiol. 2018 Jun;4(6):757-768. doi: 10.1016/j.jacep.2018.04.017.
5
Appropriate and Inappropriate Implantable Cardioverter Defibrillators Therapies in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Patients.致心律失常性右室心肌病/发育不良患者中合适与不合适的植入式心律转复除颤器治疗
Cardiol Res. 2018 Aug;9(4):204-214. doi: 10.14740/cr734w. Epub 2018 Aug 10.
6
Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy.择期心律失常性右室心肌病患者行导管消融术治疗室性心动过速且不植入埋藏式心脏复律除颤器的临床疗效。
Europace. 2021 Sep 8;23(9):1428-1436. doi: 10.1093/europace/euab172.
7
Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.植入式心脏复律除颤器预防致心律失常性右室心肌病患者心源性猝死的长期随访
Clin Cardiol. 2017 Apr;40(4):216-221. doi: 10.1002/clc.22648. Epub 2017 Jan 31.
8
Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.致心律失常性右室心肌病的风险分层
Circulation. 2017 Nov 21;136(21):2068-2082. doi: 10.1161/CIRCULATIONAHA.117.030792.
9
Implantable cardiac defibrillator events in patients with arrhythmogenic right ventricular cardiomyopathy.致心律失常性右室心肌病患者的植入式心脏除颤器事件
Heart. 2022 Jan;108(1):22-28. doi: 10.1136/heartjnl-2020-318415. Epub 2021 Mar 4.
10
Arrhythmogenic Right Ventricular Cardiomyopathy: Risk Stratification and Indications for Defibrillator Therapy.致心律失常性右室心肌病：危险分层及植入式心律转复除颤器治疗的指征
Curr Cardiol Rep. 2016 Jun;18(6):57. doi: 10.1007/s11886-016-0734-9.
引用本文的文献
1
Dr Frank Marcus (1928-2022).弗兰克·马库斯博士（1928 - 2022）。
Neth Heart J. 2023 Apr;31(4):172-173. doi: 10.1007/s12471-023-01774-3. Epub 2023 Mar 20.
2
Sudden cardiac death in cardiomyopathies: acting upon "acceptable" risk in the personalized medicine era.心肌病中心律失常性猝死：个体化医疗时代对“可接受”风险的干预。
Heart Fail Rev. 2022 Sep;27(5):1749-1759. doi: 10.1007/s10741-021-10198-3. Epub 2022 Jan 27.
3
Running the Risk: Exercise and Arrhythmogenic Cardiomyopathy.冒险：运动与致心律失常性心肌病
Curr Treat Options Cardiovasc Med. 2021 Oct;23(10). doi: 10.1007/s11936-021-00943-0. Epub 2021 Sep 18.
4
Arrhythmogenic right ventricular cardiomyopathy.致心律失常性右室心肌病
J Arrhythm. 2018 Mar 11;34(4):356-368. doi: 10.1002/joa3.12012. eCollection 2018 Aug.
5
Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.致心律失常性右室心肌病的风险分层
Circulation. 2017 Nov 21;136(21):2068-2082. doi: 10.1161/CIRCULATIONAHA.117.030792.
6
Cardiac magnetic resonance imaging: Which information is useful for the arrhythmologist?心脏磁共振成像：哪些信息对心律失常专家有用？
World J Cardiol. 2017 Oct 26;9(10):773-786. doi: 10.4330/wjc.v9.i10.773.
本文引用的文献
1
Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment.北美多学科 ARVC 研究中心的室性心律失常：预测因素、特征和治疗。
J Am Coll Cardiol. 2014 Jul 15;64(2):119-25. doi: 10.1016/j.jacc.2014.04.035.
2
Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.运动增加致心律失常性右室心肌病/心律失常性右室发育不良相关桥粒突变携带者与年龄相关的外显率和心律失常风险。
J Am Coll Cardiol. 2013 Oct 1;62(14):1290-1297. doi: 10.1016/j.jacc.2013.06.033. Epub 2013 Jul 17.
3
Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.心脏磁共振成像在致心律失常性右室心肌病/心律失常性右室发育不良相关桥粒突变携带者心律失常风险分层中的增量价值。
J Am Coll Cardiol. 2013 Nov 5;62(19):1761-9. doi: 10.1016/j.jacc.2012.11.087. Epub 2013 Jun 27.
4
Transthoracic epicardial catheter ablation: indications, techniques, and complications.经胸心外膜导管消融术：适应证、技术和并发症。
Circ J. 2013;77(7):1672-80. doi: 10.1253/circj.cj-13-0510. Epub 2013 Jun 12.
5
Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.致心律失常性右室心肌病/发育不良患者的植入式心脏转复除颤器：患者结局、恰当和不恰当干预的发生率及并发症。
Circ Arrhythm Electrophysiol. 2013 Jun;6(3):562-8. doi: 10.1161/CIRCEP.113.000392. Epub 2013 May 14.
6
Risk stratification in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.致心律失常性右室心肌病/心律失常性右室发育不良相关桥粒突变携带者的风险分层。
Circ Arrhythm Electrophysiol. 2013 Jun;6(3):569-78. doi: 10.1161/CIRCEP.113.000233. Epub 2013 May 13.
7
Arrhythmogenic right ventricular dysplasia.致心律失常性右室心肌病。
Curr Probl Cardiol. 2013 Mar;38(3):103-23. doi: 10.1016/j.cpcardiol.2012.12.002.
8
The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention.遗传性心脏病患者一级预防的 ICD：适应证、使用和结局：与二级预防的比较。
Circ Arrhythm Electrophysiol. 2013 Feb;6(1):91-100. doi: 10.1161/CIRCEP.112.975268. Epub 2012 Dec 29.
9
Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.致心律失常性右室心肌病/发育不良患者行植入型心律转复除颤器一级预防时，植入型心律转复除颤器治疗的发生率及预测因素。
J Am Coll Cardiol. 2011 Sep 27;58(14):1485-96. doi: 10.1016/j.jacc.2011.06.043.
10
Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study.致心律失常性右室心肌病/扩张型心肌病：索引患者中的病理性桥粒突变可预测家族筛查的结果：荷兰致心律失常性右室心肌病/扩张型心肌病基因型-表型随访研究。
Circulation. 2011 Jun 14;123(23):2690-700. doi: 10.1161/CIRCULATIONAHA.110.988287. Epub 2011 May 23.
Zotero 插件